BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma

The EC approval is based on the Phase II CheckMate-744 trial in classical Hodgkin Lymphoma patients. Credit: Saiful52 / Shutterstock.com.



  • BMS FDA EC approvals